Insulin Glargine (U-100) Cartridge Systems and Pens and Retacrit
Determining the interaction of Insulin Glargine (U-100) Cartridge Systems and Pens and Retacrit and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: epoetin alfa
Brand name: Epogen, Procrit, Retacrit
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-100) Cartridge Systems and Pens-Retapamulin
- Insulin Glargine (U-100) Cartridge Systems and Pens-Retapamulin topical
- Insulin Glargine (U-100) Cartridge Systems and Pens-Retapamulin Topical application
- Insulin Glargine (U-100) Cartridge Systems and Pens-Retavase
- Insulin Glargine (U-100) Cartridge Systems and Pens-Retavase Half-Kit
- Insulin Glargine (U-100) Cartridge Systems and Pens-Reteplase
- Retacrit-Insulin Glargine (U-100) Vials
- Retacrit-Insulin Glargine (U-300) Pens
- Retacrit-Insulin glargine and lixisenatide
- Retacrit-Insulin glargine and lixisenatide Subcutaneous
- Retacrit-Insulin glargine, recombinant Subcutaneous
- Retacrit-Insulin glulisine